US-American psychiatrists investigated whether psilocybin treatment in patients with alcohol use disorder can reduce personality anomalies, thereby decreasing impulsivity and alcohol consumption.
Microdosing psychedelics such as LSD or psilocybin—taking 5 to 10% of a standard dose on a fixed schedule (e.g., every three days) without intending a full psychedelic experience—is receiving increasing media attention. A still limited number of small studies describe positive effects of microdosing on well-being and cognitive performance, as well as for depression and anxiety disorders.
This abstract describes a figure that presents the chemical structure of salvinorin A, the main active compound, along with the methods of use and commercially available forms of Salvia divinorum.